CCL2 and Huntington disease: To quantify the myocardial damage, serum levels of biomarkers of HF (NT-proBNP), myocardial fibrosis (galectin-3) and two proinflammatory cytokines (TNF-α and MCP-1) were measured in 101 HD patients and 40 HVs.